Dexmedetomidine is an equal cost alternative to propofol in transcatheter aortic valve replacement, with equivalent in-hospital and 30-day outcomes
Journal of Cardiothoracic and Vascular Anesthesia | Oct 01, 2020
Long-term bleeding risk prediction with dual antiplatelet therapy after acute coronary syndromes treated without revascularization
Circulation: Cardiovascular Quality and Outcomes | Sep 28, 2020
Optimizing atherosclerotic cardiovascular disease risk estimation for veterans with diabetes mellitus
Circulation: Cardiovascular Quality and Outcomes | Sep 27, 2020
Most read this week